Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes (DIABESITY)

Novo Nordisk logo

Novo Nordisk

Status

Completed

Conditions

Diabetes
Diabetes Mellitus, Type 2

Treatments

Drug: insulin detemir

Study type

Observational

Funder types

Industry

Identifiers

NCT00687063
NN304-3530

Details and patient eligibility

About

The study is conducted in Asia. The aim of this observational study is to evaluate the weight change from baseline while using Levemir® in subjects with type 2 diabetes mellitus under normal clinical practice conditions in India.

Enrollment

10,008 patients

Sex

All

Ages

6+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Any subject with type 2 diabetes

Exclusion criteria

  • Subjects with a hypersensitivity to insulin detemir or any of its excipient
  • Children below 6 years
  • Subjects who are pregnant, lactating or planning to become pregnant

Trial design

10,008 participants in 1 patient group

A
Treatment:
Drug: insulin detemir

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems